company background image
UVP logo

AusCann Group Holdings DB:UVP Stock Report

Last Price

€0.027

Market Cap

€11.3m

7D

0%

1Y

-47.9%

Updated

28 Nov, 2022

Data

Company Financials

AusCann Group Holdings Ltd

DB:UVP Stock Report

Market Cap: €11.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

UVP Stock Overview

Engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. More details

UVP fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

AusCann Group Holdings Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for AusCann Group Holdings
Historical stock prices
Current Share PriceAU$0.027
52 Week HighAU$0.056
52 Week LowAU$0.023
Beta1.44
1 Month Change0%
3 Month Change-5.26%
1 Year Change-47.88%
3 Year Change-77.43%
5 Year Change-94.23%
Change since IPO-80.00%

Recent News & Updates

Recent updates

Shareholder Returns

UVPDE PharmaceuticalsDE Market
7D0%2.7%0.05%
1Y-47.9%-25.3%15.2%

Return vs Industry: UVP underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Return vs Market: UVP underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is UVP's price volatile compared to industry and market?
UVP volatility
UVP Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.6%
10% most volatile stocks in DE Market12.6%
10% least volatile stocks in DE Market3.1%

Stable Share Price: UVP has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine UVP's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/an/aauscann.com.au

AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.

AusCann Group Holdings Ltd Fundamentals Summary

How do AusCann Group Holdings's earnings and revenue compare to its market cap?
UVP fundamental statistics
Market cap€11.34m
Earnings (TTM)-€16.05m
Revenue (TTM)€1.31m
8.7x
P/S Ratio
-0.7x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UVP income statement (TTM)
RevenueAU$2.04m
Cost of RevenueAU$1.70m
Gross ProfitAU$336.67k
Other ExpensesAU$25.28m
Earnings-AU$24.94m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.057
Gross Margin16.52%
Net Profit Margin-1,223.99%
Debt/Equity Ratio0%

How did UVP perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/28 19:33
End of Day Share Price 2022/08/31 00:00
Earnings2022/06/30
Annual Earnings2022/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AusCann Group Holdings Ltd is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.